Regions
European biomanufacturing is regional. Routing should be too.
CDMO Network Europe connects sponsors to regional capability across Europe’s specialized biomanufacturing ecosystem.
Different regions bring different strengths in biologics, vaccines, cell therapy, microbial fermentation, fill-finish, diagnostics, research tools, and advanced therapeutic manufacturing. The right route depends on the program.
Geography changes execution.
Regulatory path, logistics, language, capacity, and ecosystem maturity all affect CDMO fit.
Capability is uneven.
No single region is best at everything. The strongest route depends on modality and stage.
Europe needs routing.
CDMO Network Europe helps sponsors move through fragmentation with structure.
Regional Coverage
One European network. Many specialized routes.
Each regional page can act as its own landing page for sponsors seeking European development, manufacturing, analytics, or supply support.
UK & Ireland
Strong for innovation-stage biotech, translational programs, early development, advanced therapeutics, analytics, and technically complex outsourcing needs.
Explore UK & Ireland →Benelux
A practical cross-border hub for pharma infrastructure, biologics, vaccines, clinical logistics, fill-finish interfaces, and international sponsor routing.
Explore Benelux →DACH
Germany, Austria, and Switzerland are highly relevant for quality-sensitive programs, GMP maturity, engineering discipline, analytical rigor, and high-value manufacturing.
Explore DACH →France
France offers a serious route for vaccines, biologics, pharma infrastructure, public-private innovation, sterile manufacturing, and European life sciences scale.
Explore France →Iberia
Spain and Portugal are increasingly relevant for competitive European execution, growing CDMO capacity, sterile manufacturing, biologics, and scalable development support.
Explore Iberia →Nordics
The Nordics are well positioned for high-science, high-trust programs involving precision medicine, cell and gene therapy, sustainability, and innovation-driven development.
Explore Nordics →Central & Eastern Europe
Central and Eastern Europe provide expanding manufacturing options, skilled technical labor, clinical supply support, and credible routes for scalable, cost-sensitive execution.
Explore Central & Eastern Europe →Pan-European Routing
Some programs require more than one region: development in one geography, GMP manufacturing in another, analytics elsewhere, and fill-finish through a specialized partner.
Discuss routing →Choose the route by program type.
A regional CDMO decision should begin with the work itself. The same country or region may be ideal for one program and wrong for another.
Expression system, process development, DS/DP interface, analytical control, and GMP stage determine the route.
Cell therapy, viral vectors, nucleic acids, and complex modalities require specialized technical and regulatory maturity.
Fermentation, enzymes, food proteins, live biotherapeutics, and industrial biologics require different cost and scale logic.
Sterile formats, lyophilization, cold chain, clinical supply, and cross-border logistics shape the final execution path.
Regional fit is not a map. It is a decision system.
CDMO Network Europe routes programs by matching technical scope to regional strengths, operational constraints, and real execution requirements.